DK0612250T3 - Fremgangsmåder og præparater med relation til nyttige Moraxella catarrhalis-antigener - Google Patents

Fremgangsmåder og præparater med relation til nyttige Moraxella catarrhalis-antigener

Info

Publication number: DK0612250T3
Authority: DK; Denmark
Prior art keywords: moraxella catarrhalis; omps; proteins; methods; variants
Prior art date: 1991-08-15

Application number

DK92918273.1T

Other languages

English (en)

Inventor

Eric J Hansen

Merja Helminen

Isobel Maciver

Original Assignee

Univ Texas

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-08-15

Filing date

1992-08-14

Publication date

1996-11-25

1992-08-14 Application filed by Univ Texas filed Critical Univ Texas

1996-11-25 Application granted granted Critical

1996-11-25 Publication of DK0612250T3 publication Critical patent/DK0612250T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
- C07K14/212—Moraxellaceae, e.g. Acinetobacter, Moraxella, Oligella, Psychrobacter
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/1217—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Neisseriaceae (F)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Oncology (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Veterinary Medicine (AREA)
Communicable Diseases (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

DK92918273.1T 1991-08-15 1992-08-14 Fremgangsmåder og præparater med relation til nyttige Moraxella catarrhalis-antigener DK0612250T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US07/745,591 US5552146A (en)	1991-08-15	1991-08-15	Methods and compositions relating to useful antigens of Moraxella catarrhalis

Publications (1)

Publication Number	Publication Date
DK0612250T3 true DK0612250T3 (da)	1996-11-25

Family

ID=24997358

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK92918273.1T DK0612250T3 (da)	1991-08-15	1992-08-14	Fremgangsmåder og præparater med relation til nyttige Moraxella catarrhalis-antigener

Country Status (14)

Country	Link
US (3)	US5552146A (da)
EP (1)	EP0612250B1 (da)
JP (1)	JP3499868B2 (da)
KR (1)	KR100271888B1 (da)
AT (1)	ATE140627T1 (da)
AU (1)	AU666329B2 (da)
CA (1)	CA2115565C (da)
DE (1)	DE69212495T2 (da)
DK (1)	DK0612250T3 (da)
ES (1)	ES2092696T3 (da)
FI (1)	FI106844B (da)
GR (1)	GR3021423T3 (da)
NO (2)	NO308413B1 (da)
WO (1)	WO1993003761A1 (da)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2693654B1 (fr) *	1992-07-20	1994-08-26	Oreal	Médicament, notamment immunomodulateur, contenant des enveloppes ou fractions d'enveloppes de bactéries filamenteuses non photosynthétiques et non fructifiantes, et sa préparation.
ATE190502T1 (de) *	1993-05-13	2000-04-15	American Cyanamid Co	Herstellung und verwendungen von los-verminderten aussenmembran-proteinen von gram-negativen kokken
US5712118A (en) *	1993-09-29	1998-01-27	Research Foundation Of State University Of New York	Vaccine for branhamella catarrhalis
US5607846A (en) *	1994-05-17	1997-03-04	Research Foundation Of State University Of New York	Vaccine for moraxella catarrhalis
US6121427A (en) *	1994-10-24	2000-09-19	Connaught Laboratories Limited	Major outer membrane protein CD of branhamella
US6440425B1 (en) *	1995-05-01	2002-08-27	Aventis Pasteur Limited	High molecular weight major outer membrane protein of moraxella
US6335018B1 (en) *	1995-05-01	2002-01-01	Aventis Pasteur Limited	High molecular weight major outer membrane protein of moraxella
US6290970B1 (en) *	1995-10-11	2001-09-18	Aventis Pasteur Limited	Transferrin receptor protein of Moraxella
US7341727B1 (en) *	1996-05-03	2008-03-11	Emergent Product Development Gaithersburg Inc.	M. catarrhalis outer membrane protein-106 polypeptide, methods of eliciting an immune response comprising same
KR100500000B1 (ko) *	1996-05-03	2005-12-12	안텍스 바이오로직스 인코퍼레이션	모락셀라카타르할리스외측막단백질-16폴리펩티드,이의유전자서열및이의용도
US6004562A (en) *	1996-08-16	1999-12-21	The Research Foundation Of The State University Of New York	Outer membrane protein B1 of Moraxella catarrhalis
US6558677B2 (en) *	1996-10-15	2003-05-06	Wendell D. Zollinger	Vaccine against gram negative bacteria
WO1998028333A2 (en)	1996-12-20	1998-07-02	The Board Of Regents, The University Of Texas System	USPA1 AND USPA2 ANTIGENS OF $i(MORAXELLA CATARRHALIS)
GB9810084D0 (en)	1998-05-11	1998-07-08	Cortecs Uk Ltd	Proteins
EP1078065A2 (en) *	1998-05-12	2001-02-28	SMITHKLINE BEECHAM BIOLOGICALS s.a.	Compounds from moraxella catarrhalis
GB9810285D0 (en) *	1998-05-13	1998-07-15	Smithkline Beecham Biolog	Novel compounds
GB9812440D0 (en) *	1998-06-09	1998-08-05	Smithkline Beecham Biolog	Novel compounds
TR200102739T2 (tr)	1999-03-19	2001-12-21	Smithkline Beecham Biologicals S.A.	Aşı
GB9914945D0 (en) *	1999-06-25	1999-08-25	Smithkline Beecham Biolog	Novel compounds
GB9921691D0 (en)	1999-09-14	1999-11-17	Smithkline Beecham Sa	Novel compounds
GB0022742D0 (en)	2000-09-15	2000-11-01	Smithkline Beecham Biolog	Vaccine
GB0103171D0 (en)	2001-02-08	2001-03-28	Smithkline Beecham Biolog	Vaccine composition
KR20050039839A (ko)	2002-08-02	2005-04-29	글락소스미스클라인 바이오로지칼즈 에스.에이.	Ｌｇｔｂ- 나이세리아 메닌기티디스로부터의 ｌ2 및/또는ｌ3 면역유형 리포올리고사카라이드를 포함하는 백신 조성물
GB0220194D0 (en)	2002-08-30	2002-10-09	Chiron Spa	Improved vesicles
GB0424092D0 (en)	2004-10-29	2004-12-01	Chiron Srl	Immunogenic bacterial vesicles with outer membrane proteins
US7709001B2 (en)	2005-04-08	2010-05-04	Wyeth Llc	Multivalent pneumococcal polysaccharide-protein conjugate composition
KR102220506B1 (ko)	2005-04-08	2021-03-02	와이어쓰 엘엘씨	다가 폐렴구균 다당류-단백질 접합체 조성물
TWI457133B (zh)	2005-12-13	2014-10-21	Glaxosmithkline Biolog Sa	新穎組合物
GB0607088D0 (en)	2006-04-07	2006-05-17	Glaxosmithkline Biolog Sa	Vaccine
DK3017827T3 (da)	2005-12-22	2019-02-18	Glaxosmithkline Biologicals Sa	Pneumokok-polysaccharidkonjugat-vaccine
NZ569417A (en)	2006-01-17	2012-04-27	Arne Forsgren	A novel surface exposed haemophilus influenzae protein (protein E; pE)
CN101883583B (zh)	2007-06-26	2017-05-17	葛兰素史密丝克莱恩生物有限公司	含有肺炎链球菌荚膜多糖缀合物的疫苗
EP2296699A4 (en)	2008-05-30	2013-11-13	U S A As Represented By The Secretary Of The Army On Behalf Of Walter Reed Army	POLYVALENT MENINGOCOCCULAR FUEL WITH NATIVE OUTER MEMBRANE VESICLES, METHOD OF MANUFACTURE AND USE
GB201003922D0 (en)	2010-03-09	2010-04-21	Glaxosmithkline Biolog Sa	Conjugation process
GB201003924D0 (en)	2010-03-09	2010-04-21	Glaxosmithkline Biolog Sa	Immunogenic composition
CA2792683A1 (en)	2010-03-10	2011-09-15	Glaxosmithkline Biologicals S.A.	Neisserial fhbp vaccine composition
GB201103836D0 (en)	2011-03-07	2011-04-20	Glaxosmithkline Biolog Sa	Conjugation process
GB201518684D0 (en)	2015-10-21	2015-12-02	Glaxosmithkline Biolog Sa	Vaccine
GB201621686D0 (en)	2016-12-20	2017-02-01	Glaxosmithkline Biologicals Sa	Novel methods for inducing an immune response
IE20190085A3 (en)	2017-05-30	2023-07-19	Glaxosmithkline Biologicals Sa	Novel methods for manufacturing an adjuvant
MX2020005481A (es)	2017-12-01	2020-12-07	Glaxosmithkline Biologicals Sa	Purificacion de saponina.
CN112601545A (zh)	2018-08-07	2021-04-02	葛兰素史密丝克莱恩生物有限公司	工艺和疫苗
EP3886901A1 (en)	2018-11-29	2021-10-06	GlaxoSmithKline Biologicals S.A.	Methods for manufacturing an adjuvant
EP3980044A1 (en)	2019-06-05	2022-04-13	GlaxoSmithKline Biologicals SA	Saponin purification
GB202205833D0 (en)	2022-04-21	2022-06-08	Glaxosmithkline Biologicals Sa	Bacteriophage
WO2024017827A1 (en)	2022-07-19	2024-01-25	Glaxosmithkline Biologicals Sa	Continuous process for vaccine production

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5030556A (en) *	1989-03-30	1991-07-09	Danielle Beaulieu	Species-specific DNNA probe for the detection of Branhamella catarrhalis

1991
- 1991-08-15 US US07/745,591 patent/US5552146A/en not_active Expired - Lifetime
1992
- 1992-08-14 EP EP92918273A patent/EP0612250B1/en not_active Expired - Lifetime
- 1992-08-14 AU AU24878/92A patent/AU666329B2/en not_active Ceased
- 1992-08-14 JP JP50448193A patent/JP3499868B2/ja not_active Expired - Fee Related
- 1992-08-14 CA CA002115565A patent/CA2115565C/en not_active Expired - Fee Related
- 1992-08-14 KR KR1019940700431A patent/KR100271888B1/ko not_active IP Right Cessation
- 1992-08-14 AT AT92918273T patent/ATE140627T1/de not_active IP Right Cessation
- 1992-08-14 DK DK92918273.1T patent/DK0612250T3/da active
- 1992-08-14 DE DE69212495T patent/DE69212495T2/de not_active Expired - Fee Related
- 1992-08-14 WO PCT/US1992/006869 patent/WO1993003761A1/en active IP Right Grant
- 1992-08-14 ES ES92918273T patent/ES2092696T3/es not_active Expired - Lifetime
1994
- 1994-02-14 FI FI940681A patent/FI106844B/fi active
- 1994-02-14 NO NO940502A patent/NO308413B1/no unknown
- 1994-09-19 US US08/193,150 patent/US5759813A/en not_active Expired - Fee Related
1995
- 1995-05-25 US US08/450,002 patent/US5599693A/en not_active Expired - Lifetime
1996
- 1996-10-23 GR GR960402795T patent/GR3021423T3/el unknown
2000
- 2000-05-09 NO NO20002413A patent/NO20002413L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
NO20002413D0 (no)	2000-05-09
JP3499868B2 (ja)	2004-02-23
EP0612250A1 (en)	1994-08-31
JPH07501210A (ja)	1995-02-09
CA2115565C (en)	2007-08-07
US5759813A (en)	1998-06-02
US5552146A (en)	1996-09-03
WO1993003761A1 (en)	1993-03-04
DE69212495D1 (de)	1996-08-29
ES2092696T3 (es)	1996-12-01
CA2115565A1 (en)	1993-03-04
FI940681A0 (fi)	1994-02-14
ATE140627T1 (de)	1996-08-15
AU2487892A (en)	1993-03-16
NO940502L (no)	1994-03-28
US5599693A (en)	1997-02-04
FI106844B (fi)	2001-04-30
KR100271888B1 (ko)	2000-11-15
NO308413B1 (no)	2000-09-11
FI940681L (fi)	1994-04-07
AU666329B2 (en)	1996-02-08
EP0612250B1 (en)	1996-07-24
NO20002413L (no)	2000-05-09
GR3021423T3 (en)	1997-01-31
DE69212495T2 (de)	1997-03-06
NO940502D0 (no)	1994-02-14

Publication	Publication Date	Title
DK0612250T3 (da)	1996-11-25	Fremgangsmåder og præparater med relation til nyttige Moraxella catarrhalis-antigener
PT100781A (pt)	1993-09-30	Sequencias de dna codificadoras de proteinas de superficie externa, proteinas contendo as referidas sequencias, obtidas a partir de borrelia burgdorferi, e vacinas contendo as referidas proteinas
ATE127345T1 (de)	1995-09-15	Stressproteine und verwendungen dafür.
ATE317013T1 (de)	2006-02-15	Antigen omp26 aus haemophilus influenzae
FI102382B1 (fi)	1998-11-30	Ilmentämisjärjestelmä ihmisen respiratory syncytial -viruksen glykoproteiinien immunogeenisia fragmentteja sisältäviä kimeerisiä glykoproteiineja varten
EP0755259A4 (en)	1999-12-22	CHIMERAL cDNA CLONES OF THE VIRUS OF INFECTIOUS BURSAL DISEASE, EXPRESSION PRODUCTS AND Vaccines Based On Them
DK0461177T3 (da)	1999-09-13	Humant intra-acrosomalt spermantigen til anvendelse i en svangerskabsforebyggende vaccine
ATE80310T1 (de)	1992-09-15	Antigenische proteine, dieselben enthaltende vakzine, schuetzende antikoerper dagegen fuer die verhuetung von durch eimeria tenella verursachte coccidiosis.
DE69419966D1 (de)	1999-09-16	Impstoff gegen Streptococcus suis-Infektion
DK482788A (da)	1988-10-31	Vacciner mod og diagnostiske bestemmelser af haemophilus influenzae
FI924457A0 (fi)	1992-10-02	Kompositioner och behandlingsfoerfarande foer lunginflammation i djur
ATA171686A (de)	1990-02-15	Verfahren zur herstellung von gegen pseudomonas aeruginosa infektionen wirksamen praeparationen
YU12991A (sh)	1994-06-10	Rekombinantne vakcine protiv kokcidioze-5-7 eimeria površinski antigen
ATE124420T1 (de)	1995-07-15	Impfstoffe und testsätze für haemophilus influenzae.
FR2736064B1 (fr)	1997-09-05	Epitopes protecteurs de l'adenyl cyclase-hemolysine(ac-hty). leur application au traitement ou a la prevention des infections par bordetella
NO923828L (no)	1992-10-01	Polypeptider, nyttige til diagnose av og behandling mot mycoplasma-infeksjoner hos dyr